ExamOne News

CPU-to-CPU update: Hepatitis C reportable test

August 23, 2018

We are pleased to announce we are adding HCV RNA, Quant RT-PCR as a reportable test. In order to receive this information in your data feed, configuration will be necessary. Please see below for new result ID.  CPU-to-CPU update The following results will be added to the panel of blood results available. Test name: HCV… Read More

Exam center expansion will provide life insurers and applicants more appointment options

July 23, 2018

In today’s on-the-go world, many applicants prefer the convenience of completing their life insurance exam on the way to their next meeting or event. Today, ExamOne offers applicants the choice of more than 700 exam center locations across the country. In order to provide even more options and appointments, ExamOne and Quest Diagnostics are expanding… Read More

Quest Diagnostics Names Stuart Smith as President, ExamOne

October 16, 2017

LENEXA, KAN., October 16, 2017, ExamOne, the leader in helping insurers meet their underwriting needs, announced today that Stuart Smith will lead all aspects of the business which operates in the U.S. and Canada. Stuart replaces long-time ExamOne leader Troy Hartman, who has decided to leave the organization to pursue other interests. Stuart will be based… Read More

Life Insurance Awareness Month: The value of knowing your loved ones are protected

August 31, 2017

September is Life Insurance Awareness Month. Now, more than ever, it’s important to remind the public of the value of life insurance. According to the 2017 Insurance Barometer study, 41% of Americans still do not have any life insurance. With the nonprofit foundation Life Happens*, we are committed to educating individuals on the necessary steps… Read More

ExamOne Completes Acquisition of Watermark Insurance Services Inc. and BW Underwriting Services Inc.

August 2, 2017

ExamOne, a Quest Diagnostics Company, and the nation’s leading provider of paramedical information services, today announced that it has completed the previously announced acquisition of Watermark Insurance Services, Inc. and BW Underwriting Services, Inc. As a result of the transaction, life insurers and applicants now have access to the most extensive range of innovative services,… Read More

ExamOne offers expanded opioid panel

July 6, 2017

As prescription drug misuse has risen to epidemic proportions in this country, the focus is centering around semi-synthetic opioids. Because the opiate screen included in the full drug panels detects only codeine, morphine and heroin, ExamOne will offer an expanded opioid panel. Drug overdose deaths and opioid-involved deaths continue to increase in the United States. The… Read More

ExamOne Expands Services in Canada with Acquisition of Watermark Insurance Services Inc. and BW Underwriting Services Inc.

June 22, 2017

Transaction to Enhance Integrated Risk Assessment Services for Insurers and Life Insurance Applicants in Canada LENEXA, KAN., June 20, 2017, ExamOne, the leader in helping insurers meet their underwriting needs, has entered into a definitive agreement to acquire Watermark Insurance Services Inc. and BW Underwriting Services Inc., national providers of underwriting services in Canada. Based in… Read More

Introducing ExamOne Health Solutions

March 20, 2017

For nearly five decades, ExamOne has been a leader in providing comprehensive risk analysis services to the life insurance industry. Along the way, we continuously expanded and evolved our core competencies to serve the healthcare industry. Today, we are proud to introduce ExamOne Health Solutions. Leveraging the capabilities which have become our core competencies, we… Read More

Innovation in Insurance Underwriting: ExamOne Introduces Risk Identifier

February 6, 2017

— Real-time, health data product takes a personalized approach to risk assessment — Underwriters have new tool to guide smarter decisions and receive instant decision-making results  LENEXA, Kansas, February 6, 2017 – ExamOne, a Quest Diagnostics company and leader in helping insurers meet their underwriting needs, announced today the introduction of Risk IdentifierTM. The innovative… Read More

Updated laboratory requirement for all laboratory-developed tests

January 20, 2017

The most recent College of American Pathologist (CAP) checklist¹ contains an updated requirement (COM.40630) for all laboratory-developed tests (LDTs). We must provide the following statement on our laboratory reports: The following tests were developed and their analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA…. Read More